Results 221 to 230 of about 137,320 (331)

First Annual Report for Robot‐Assisted Surgery Based on the National Clinical Database 2019 in Japan: Report on Three Major Gastrointestinal Fields

open access: yesAsian Journal of Endoscopic Surgery, Volume 19, Issue 1, January/December 2026.
ABSTRACT Aim The adoption of robot‐assisted surgery (RAS) in Japan has progressed significantly since its initial approval in 2009. RAS gradually expanded into various surgical fields with 35 procedures now covered under Japan's national health insurance.
Ichiro Takemasa   +19 more
wiley   +1 more source

Giant hydronephrosis secondary to ureterolithiasis: A case report. [PDF]

open access: yesUrol Case Rep
Cardoso LL   +8 more
europepmc   +1 more source

Nephrocutaneous Fistula: An Unusual Nephrectomy Indication in Percutaneous Nephrolithotomy

open access: diamond, 2019
Mehmet Yiğit Yalçın   +8 more
openalex   +1 more source

Artificial intelligence in genitourinary pathology

open access: yesHistopathology, Volume 88, Issue 1, Page 353-373, January 2026.
Artificial intelligence (AI) is now practical in genitourinary pathology. We synthesize evidence and economics into a two‐part playbook: VALIDATED (governance) and ORCHESTRATE (operations), to safely deploy AI tools across prostate, bladder, kidney and testis.
Ankush U Patel   +2 more
wiley   +1 more source

Outcomes of Nivolumab‐Plus‐Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J‐ENCORE Study

open access: yesInternational Journal of Urology, Volume 33, Issue 1, January 2026.
ABSTRACT Objectives J‐ENCORE is a multicenter prospective observational study in Japan involving advanced or metastatic renal cell carcinoma patients receiving nivolumab‐plus‐ipilimumab (NIVO+IPI) as first‐line treatment. The minimum 1‐year observation revealed the efficacy and safety of NIVO+IPI comparable to those in CheckMate 214, and evaluated ...
Tomokazu Sazuka   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy